CD71+红系祖细胞中高表达红铁酮预测骨髓增生异常综合征患者生存更优
该研究分析了111例骨髓增生异常综合征(MDS)患者CD71+红系祖细胞中红铁酮(ERFE)和GDF15的表达及其对生存的影响。ERFE表达在MDS中高度异常,且与预后显著相关,独立于IPSS分层;ERFE高表达预测IPSS低/中-1亚组及正常核型患者的总生存(OS)更优。
要点
- ERFE在CD71+红系祖细胞中的表达与MDS预后相关且独立于IPSS分层。
- ERFE高表达预测IPSS低/中-1亚组及正常核型患者OS更优。
- SF3B1突变患者ERFE表达升高,但ERFE在SF3B1野生型和突变型亚组中均预测OS。
核心结论
- ERFE表达与MDS结局强相关,提示ERFE可能参与MDS的分子发病机制。
研究设计与样本
- 分析了111例MDS患者CD71+红系祖细胞中ERFE和GDF15的表达并评估其对生存的影响。
主要发现
- ERFE和GDF15在MDS中表达高度异常。
- ERFE表达与MDS预后高度相关且独立于IPSS分层。
- ERFE高表达预测IPSS低/中-1亚组和正常核型患者OS更优。
- GDF15有类似观察但未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ineffective erythropoiesis and iron overload are common in myelodysplastic syndromes (MDS). Erythroferrone (ERFE) and growth/differentiation factor 15 (GDF15) are two regulators of iron homeostasis produced by erythroid progenitors. Elevated systemic levels of ERFE and GDF15 in MDS are associated with dysregulated iron metabolism and iron overload, which is especially pronounced in MDS with SF3B1 gene mutations. However, the role of ERFE and GDF15 in MDS pathogenesis and their influence on disease progression are largely unknown. Here, we analyzed the expression of ERFE and GDF15 in CD71+ erythroid progenitors of n = 111 MDS patients and assessed their effects on patient survival. The expression of ERFE and GDF15 in MDS was highly aberrant. Unexpectedly, ERFE expression in erythroprogenitors was highly relevant for MDS prognosis and independent of International Prognostic Scoring System (IPSS) stratification. Although ERFE expression was increased in patients with SF3B1 mutations, it predicted overall survival (OS) in both the SF3B1wt and SF3B1mut subgroups. Of note, ERFE overexpression predicted superior OS in the IPSS low/Int-1 subgroup and in patients with normal karyotype. Similar observations were made for GDF15, albeit not reaching statistical significance. In summary, our results revealed a strong association between ERFE expression and MDS outcome, suggesting a possible involvement of ERFE in molecular MDS pathogenesis.
引用
- Riabov V, Mossner M, Stöhr A, et al. High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes. Br J Haematol. 2021. PMID: 33486765. doi:10.1111/bjh.17314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。